Fund Holdings — Stonepine Capital Management, LLC

Total Portfolio Value:
$108.90M
Total Bought:
$18.20M
Total Sold:
$36.47M
Net Transaction:
-$18.27M
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Adma Biologics Inc3,426,8821,870,000-1,556,882$22.62M$20.91M19.20%-$1.71M
Alimera Sciences Inc4,051,0723,511,816-539,256$15.80M$19.53M17.93%+$3.73M
Evolus, Inc.(EOLS)2,674,3561,657,611-1,016,745$37.44M$17.99M16.52%-$19.46M
Lakefront Biotherapeutics NVADR(LKFT)393,634485,000+91,366$12.68M$12.02M11.04%-$656.7K
Revance Therapeutics Inc1,976,3422,800,000+823,658$9.72M$7.20M6.61%-$2.53M
Xoma Corp253,770250,129-3,641$6.10M$5.93M5.44%-$177.6K
Anika Therapeutics Inc60,949165,397+104,448$1.55M$4.19M3.85%+$2.64M
TELA Bio, Inc.(TELA)688,200625,645-62,555$3.90M$2.94M2.70%-$961.6K
Rigel Pharmaceuticals, Inc.(RIGL)0305,000+305,000$0$2.51M2.30%+$2.51M
Optinose Inc02,350,010+2,350,010$0$2.44M2.24%+$2.44M
Aclaris Therapeutics, Inc.(ACRS)01,927,446+1,927,446$0$2.12M1.95%+$2.12M
Scpharmaceuticals Inc446,776421,703-25,073$2.24M$1.83M1.68%-$408.4K
Aurinia Pharmaceuticals Inc.(AUPH)0300,000+300,000$0$1.71M1.57%+$1.71M
Milestone Pharmaceuticals Inc.(MIST)1,462,2961,239,199-223,097$2.62M$1.64M1.50%-$981.8K
Aytu Biopharma Inc472,469472,4690$1.44M$1.38M1.27%-$56.7K
Kiora Pharmaceuticals Inc0200,000+200,000$0$840.0K0.77%+$840.0K
Adicet Bio Inc141,548609,446+467,898$332.6K$737.4K0.68%+$404.8K
Exagen Inc.(XGN)384,600358,697-25,903$611.5K$652.8K0.60%+$41.3K
Kezar Life Sciences Inc01,050,452+1,050,452$0$630.3K0.58%+$630.3K
Aprea Therapeutics, Inc.(APRE)0137,174+137,174$0$558.3K0.51%+$558.3K
2seventy Bio Inc0100,000+100,000$0$385.0K0.35%+$385.0K
Eton Pharmaceuticals, Inc.(ETON)0110,000+110,000$0$361.9K0.33%+$361.9K
Ironwood Pharmaceuticals, Inc.CL A(IRWD)048,012+48,012$0$313.0K0.29%+$313.0K
Acadia Pharmaceuticals Inc05,000+5,000$0$81.3K0.07%+$81.3K
Surrozen, Inc.(SRZN)01,584+1,584$0$17.3K0.02%+$17.3K
CalciMedica, Inc.(CALC)522,6020-522,602$2.17M$0—-$2.17M
Io Biotech Inc156,1670-156,167$270.2K$0—-$270.2K
Nektar Therapeutics(NKTR)3,480,4090-3,480,409$3.25M$0—-$3.25M
Rezolute, Inc.(RZLT)121,4790-121,479$309.8K$0—-$309.8K
Rigel Pharmaceuticals Inc1,040,2410-1,040,241$1.54M$0—-$1.54M
SCYNEXIS, Inc.(SCYX)95,6370-95,637$140.6K$0—-$140.6K
Xeris Biopharma Holdings Inc598,0860-598,086$1.32M$0—-$1.32M
Page 1 of 1
Stonepine Capital Management, LLC — 13F Holdings — Q2 2024 | TickerTrail